Gates Foundation Pledges $120 Million to Help Get Covid Pills Quickly to Poor Countries

[news]

Regulatory hurdles and supply chain issues could slow efforts to produce generic versions of Merck’s antiviral molnupiravir for developing nations, despite licensing agreements.

More... (https://www.nytimes.com/2021/10/20/health/covid-molnupiravir-gates-foundation.html)